References
- Dwyer J M. Manipulating the immune system with immune globulin. N Engl J Med 1992; 326: 107–116
- Eibl M M. Gamma globulin therapy. Curr Opin Pediatrics 1990; 2: 935–940
- Dwyer J M, Benson E M, Currie J N, O'Day J. Intravenously administered IgG for the treatment of thyroid eye disease. Immunotherapy with Intravenous Immunoglobulins, P Imbach. Academic Press, London 1991; 387–394
- Antonelli A, Saracino A, Alberti B, Canapicchi R, Cartei F, Lepri A, et al. High dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. Acta Endocrinol 1992; 126: 13–23
- Antonelli A, Navarranne A, Palla R, Alberti B, Saracino A, Mestre C, et al. Pretibial myxedema and high-dose intravenous immunoglobulin treatment. Thyroid 1994; 4: 399–408
- Hurez V, Kaveri S V, Kazatchkine M D. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases. J Autoimmunol 1993; 6: 675–681
- Agostini G, Antonelli A. Le immunoglobuline per via endovenosa. Caratteristiche generali e principali applicazioni cliniche. Clin Ter 1992; 141: 17–32
- McGregor A M, Rees Smith B, Hall R, Collins P N, Bottazzo G F, Petersen M M. Specificity of the immunosuppressive action of carbimazole in Graves' disease. Br Med J 1982; 284: 1750
- Katakura M, Yamada T, Aizawa T, Hiromatsu K, Ishihara M, Takasu N, et al. Presence of antideoxyribonucleic acid antibodies in patients with hyperthyroidism of Graves' disease. J Clin Endocrinol Metabol 1987; 64: 405–408
- Baethge B A, Levine S N, Wolf R E. Antibodies to nuclear antigens in Graves' disease. J Clin Endocrinol Metabol 1988; 485–488
- McGregor A M, Petersen M M, McIahlan S M, Rooke P, Rees Smith B, Hall R. Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 1980; 303: 302–307
- McDermott M T, West S G, Emlen J W, Kidd G S. Antideoxyribonucleic acid antibodies in Graves' disease. J Clin Endocrinol Metabol 1990; 71: 509–511
- Petri M, Karlson E W, Cooper D S, Ladenson P W. Autoantibody tests in autoimmune thyroid diseases. J Rheum 1991; 18: 1529–1531
- Loviselli A, Velluzzi F, Pala R, Marcello A, Nurchis P, Mathieu A, et al. Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 1992; 14: 33–36
- Tachi J, Amoni N, Iwatani Y, Tamaki H, Mori M, Aozaso M, Tanizawa Miyai K. Increase in antideoxyribonucleic acid antibody titer in postpartum aggravation of autoimmune thyroid disease. J Clin Endocrinol Metabol 1988; 67: 1049–1053
- Wall J R. Report of a symposium on ‘Progress in Thyroid Associated Ophthalmopathy’. September, 1995. Pittsburgh, Autoimmunity, (in press)
- Van Schaik I N, Lundkvist I, Vermeulen M, Brand A. Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 1992; 12: 1–10
- Antonelli A, Palla R, Casarosa L, Alberti B, Saracino A, Gambuzza C, Baschieri L. In vitro solubilization of deposits of IgG immune complexes by gamma-globulins in patients with Graves' disease, Graves' ophthalmopathy, pretibial myxoedema and Hashimoto's thyroiditis. Pharmacol Res 1992; 26: 170–171
- Van Schaik I N. Antibody response and intravenous immunoglobulin treatment in immune-mediated peripheral neuropathies. Cip-Data Royal Library, The Hague-Amsterdam 1995
- Dietrich G, Kazatchkine M D. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contains antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human antithyroglobulin autoantibodies. J Clin Invest 1990; 85: 620–625
- Dietrich G, Kaveri S V, Kazatchkine M D. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992; 62: S73–S81
- Dietrich G, Varela F J, Hurez V, Bouanani M, Kazatchkine M D. Selection of the expressed B cell repertoire by infusion of normal immunoglobulin G in a patient with autoimmune thyroiditis. Eur J Immunol 1993; 23: 2945–2950